Sunshine Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.12	9.69	16.29	21.83	2.05
Short-Term Investments	-	-	-	-	0.01
Cash & Short-Term Investments	9.12	9.69	16.29	21.83	2.05
Cash Growth	-5.81%	-40.55%	-25.36%	963.27%	105.79%
Accounts Receivable	3.46	3.87	2.55	1.91	0.01
Receivables	3.46	3.87	2.55	1.91	0.01
Inventory	13.47	11.28	5.73	3.29	0.11
Prepaid Expenses	0.8	1.13	0.31	0.28	0.03
Total Current Assets	26.85	25.97	24.89	27.31	2.2
Property, Plant & Equipment	1.34	1.48	1.01	1.15	0.01
Other Intangible Assets	1.89	3.02	1.44	0.78	-
Long-Term Deferred Tax Assets	-	0.09	-	-	-
Total Assets	30.08	30.56	27.35	29.24	2.2
Accounts Payable	5.66	5.54	2.59	2.8	0.04
Accrued Expenses	-	-	-	-	0.05
Current Portion of Leases	0.22	0.21	0.12	0.12	-
Current Income Taxes Payable	0.27	0.27	0.3	0.37	-
Other Current Liabilities	0.3	0.3	2.55	3.63	-
Total Current Liabilities	6.44	6.31	5.55	6.93	0.09
Long-Term Debt	-	-	-	-	1.9
Long-Term Leases	0.6	0.74	0.54	0.64	-
Long-Term Deferred Tax Liabilities	-	-	0.05	0.04	-
Total Liabilities	7.04	7.06	6.14	7.62	1.99
Common Stock	0	0	0	0.02	0
Additional Paid-In Capital	98.1	93.35	84.42	80.84	32.79
Retained Earnings	-75.02	-69.04	-63.91	-59.4	-32.66
Comprehensive Income & Other	-0.07	-0.83	0.7	0.16	-0.02
Total Common Equity	23.03	23.49	21.21	21.63	0.11
Shareholders' Equity	23.04	23.5	21.21	21.63	0.21
Total Liabilities & Equity	30.08	30.56	27.35	29.24	2.2
Total Debt	0.81	0.95	0.66	0.77	1.9
Net Cash (Debt)	8.31	8.73	15.63	21.06	0.15
Net Cash Growth	-4.84%	-44.14%	-25.77%	13687.37%	-
Net Cash Per Share	2.00	12.45	1219.08	-	-
Filing Date Shares Outstanding	4.91	2.71	0.05	0.01	-
Total Common Shares Outstanding	4.91	2.58	0.01	0.01	-
Working Capital	20.41	19.65	19.34	20.38	2.1
Book Value Per Share	4.69	9.10	1513.44	1915.04	-
Tangible Book Value	21.14	20.47	19.76	20.85	0.11
Tangible Book Value Per Share	4.31	7.93	1410.37	1846.25	-
Machinery	-	0.79	0.54	0.48	-
Leasehold Improvements	-	0.09	0.02	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q